Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Heartbeam Inc (BEAT)

Heartbeam Inc (BEAT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 75,995
  • Shares Outstanding, K 26,665
  • Annual Sales, $ 0 K
  • Annual Income, $ -14,640 K
  • EBIT $ -19 M
  • EBITDA $ -19 M
  • 60-Month Beta -0.98
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 15.77

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.16
  • Growth Rate Est. (year over year) +624,475.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.22 +37.84%
on 11/15/24
3.24 -5.56%
on 11/29/24
+0.65 (+26.97%)
since 10/29/24
3-Month
2.00 +53.00%
on 09/24/24
3.24 -5.56%
on 11/29/24
+0.85 (+38.46%)
since 08/29/24
52-Week
1.06 +188.68%
on 12/19/23
3.39 -9.72%
on 05/29/24
+1.66 (+118.57%)
since 11/29/23

Most Recent Stories

More News
HeartBeam (NASDAQ: BEAT) Presents Positive Data for Groundbreaking Tech at AHA Conference

HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights wherever the patient is, today announced the results from two studies...

BEAT : 3.08 (+7.93%)
HeartBeam (NASDAQ: BEAT) Advances Toward Commercialization of Cardiac Care Tech with FDA Submissions

HeartBeam (NASDAQ: BEAT), reported steady progress in its third quarter financial and operational results, advancing its cardiac care technology through key FDA 510(k) submissions and strategic leadership...

BEAT : 3.08 (+7.93%)
HeartBeam (NASDAQ: BEAT) Wins 2024 Digital Health Hub Award for Innovation in Cardiac Care

HeartBeam (NASDAQ: BEAT), a medical technology company focused on advancing cardiac care, was recognized with the 2024 Digital Health Hub Rising Star award in the ‘Home Health Diagnostic’ category...

BEAT : 3.08 (+7.93%)
HeartBeam (NASDAQ: BEAT) Appoints Robert Eno as New CEO to Lead Next Phase of Growth

HeartBeam (NASDAQ: BEAT) has appointed Robert Eno as its new chief executive officer, effective Oct. 21, 2024. Eno, who joined the company as President in January 2023, will focus on guiding HeartBeam...

BEAT : 3.08 (+7.93%)
HeartBeam (NASDAQ: BEAT) Releases Q2 2024 Financial Report, Operational Update

HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through the power of personalized insights, is reporting on financial and operations results for its second quarter...

BEAT : 3.08 (+7.93%)
HeartBeam (NASDAQ: BEAT) Announces Conference Call, Webcast to Discuss Q2 Results

HeartBeam(NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through the power of personalized insights, has scheduled a conference call and webcast to discuss its second-quarter...

BEAT : 3.08 (+7.93%)
HeartBeam (NASDAQ: BEAT) Announces Conference Call, Webcast to Discuss Q2 Results

HeartBeam(NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through the power of personalized insights, has scheduled a conference call and webcast to discuss its second-quarter...

BEAT : 3.08 (+7.93%)
HeartBeam (NASDAQ: BEAT) Announces Positive Study Data for Its AI Program

HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through the power of personalized insights, today announced the results of a new study demonstrating that HeartBeam...

BEAT : 3.08 (+7.93%)
HeartBeam (NASDAQ: BEAT) Releases Q1 2024 Financial, Operational Report

HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through the power of personalized insights, is reporting on its financial and operational results for first quarter...

BEAT : 3.08 (+7.93%)

Business Summary

HeartBeam Inc. is a development stage digital healthcare company with proprietary ECG telemedicine technology. HeartBeam Inc. is based in SANTA CLARA, Calif.

See More

Key Turning Points

3rd Resistance Point 3.04
2nd Resistance Point 2.98
1st Resistance Point 2.91
Last Price 3.08
1st Support Level 2.78
2nd Support Level 2.72
3rd Support Level 2.65

See More

52-Week High 3.39
Last Price 3.08
Fibonacci 61.8% 2.50
Fibonacci 50% 2.22
Fibonacci 38.2% 1.95
52-Week Low 1.06

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar